Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer - PubMed
Prognostic value of expression of ERCC1, thymidylate synthase, and glutathione S-transferase P1 for 5-fluorouracil/oxaliplatin chemotherapy in advanced gastric cancer
H-C Kwon et al. Ann Oncol. 2007 Mar.
Free article
Abstract
Background: The aim of this study was to determine whether expressions of the excision repair cross-complementing (ERCC1), thymidylate synthase (TS), and glutathione S-transferase P1 (GSTP1) predict clinical outcome in patients with advanced gastric cancer treated with fluorouracil (5-fluorouracil)/oxaliplatin chemotherapy.
Patients and methods: The study population consisted of 64 advanced gastric cancer patients (median age 51 years). Patients were treated with oxaliplatin 85 mg/m(2) as a 2-h infusion at day 1 plus leucovorin 20 mg/m(2) over 10 min, followed by 5-FU bolus 400 mg/m(2) and 22-h continuous infusion of 600 mg/m(2) at days 1-2. Treatment was repeated in 2-week intervals. The expressions of ERCC1, TS, and GSTP1 of primary tumors were examined by immunohistochemistry.
Results: The positive rates of ERCC1, TS, and GSTP1 were 70.3%, 29.7%, and 50.0%, respectively. The patients without ERCC1 expression were more likely to respond to chemotherapy (P = 0.045). There were no significant differences between response and TS or GSTP1 expression pattern (P = 0.813, P = 0.305, respectively). Median overall survival (OS) was significantly longer in patients without ERCC1 expression (P = 0.0396). TS or GSTP1 expression were not related to survival (P = 0.4578, P = 0.8121, respectively). Multivariate analysis revealed that ERCC1 expression significantly impacted on OS (hazard ratio 1.92, P = 0.037).
Conclusion: Immunohistochemical studies for ERCC1 may be useful in prediction of the clinical outcome in advanced gastric cancer patients treated with 5-FU and oxaliplatin.
Similar articles
-
Kim SH, Kwon HC, Oh SY, Lee DM, Lee S, Lee JH, Roh MS, Kim DC, Park KJ, Choi HJ, Kim HJ. Kim SH, et al. Am J Clin Oncol. 2009 Feb;32(1):38-43. doi: 10.1097/COC.0b013e31817be58e. Am J Clin Oncol. 2009. PMID: 19194123
-
Noda E, Maeda K, Inoue T, Fukunaga S, Nagahara H, Shibutani M, Amano R, Nakata B, Tanaka H, Muguruma K, Yamada N, Yashiro M, Ohira M, Ishikawa T, Hirakawa K. Noda E, et al. Hepatogastroenterology. 2012 Jan-Feb;59(113):130-3. doi: 10.5754/hge11022. Hepatogastroenterology. 2012. PMID: 21940361
-
Squires MH 3rd, Fisher SB, Fisher KE, Patel SH, Kooby DA, El-Rayes BF, Staley CA 3rd, Farris AB 3rd, Maithel SK. Squires MH 3rd, et al. Cancer. 2013 Sep 1;119(17):3242-50. doi: 10.1002/cncr.28175. Epub 2013 May 29. Cancer. 2013. PMID: 23719746 Free PMC article.
-
Wang Z, Chen JQ, Liu JL, Qin XG, Huang Y. Wang Z, et al. BMC Gastroenterol. 2012 Sep 29;12:137. doi: 10.1186/1471-230X-12-137. BMC Gastroenterol. 2012. PMID: 23020798 Free PMC article. Review.
-
Yin M, Yan J, Martinez-Balibrea E, Graziano F, Lenz HJ, Kim HJ, Robert J, Im SA, Wang WS, Etienne-Grimaldi MC, Wei Q. Yin M, et al. Clin Cancer Res. 2011 Mar 15;17(6):1632-40. doi: 10.1158/1078-0432.CCR-10-2169. Epub 2011 Jan 28. Clin Cancer Res. 2011. PMID: 21278243 Free PMC article. Review.
Cited by
-
Omics Screening for Pharmaceutical Efficacy and Safety in Clinical Practice.
Monte AA, Vasiliou V, Heard KJ. Monte AA, et al. J Pharmacogenomics Pharmacoproteomics. 2012 Mar 16;S5:001. doi: 10.4172/2153-0645.s5-001. J Pharmacogenomics Pharmacoproteomics. 2012. PMID: 23264882 Free PMC article.
-
Sun Y, Pan J, Tong X, Chen E, Yan W, Wu M, Qu Q, Qu J. Sun Y, et al. J Cancer. 2019 Jun 2;10(13):2915-2926. doi: 10.7150/jca.31130. eCollection 2019. J Cancer. 2019. PMID: 31281468 Free PMC article.
-
XPF expression correlates with clinical outcome in squamous cell carcinoma of the head and neck.
Vaezi A, Wang X, Buch S, Gooding W, Wang L, Seethala RR, Weaver DT, D'Andrea AD, Argiris A, Romkes M, Niedernhofer LJ, Grandis JR. Vaezi A, et al. Clin Cancer Res. 2011 Aug 15;17(16):5513-22. doi: 10.1158/1078-0432.CCR-11-0086. Epub 2011 Jul 7. Clin Cancer Res. 2011. PMID: 21737503 Free PMC article.
-
Oh SY, Kwon HC, Kim SH, Lee S, Lee JH, Graves CA, Camphausen K, Kim HJ. Oh SY, et al. Chemotherapy. 2012;58(6):426-34. doi: 10.1159/000345918. Epub 2013 Jan 4. Chemotherapy. 2012. PMID: 23295255 Free PMC article. Clinical Trial.
-
Prochnow S, Wilczak W, Bosch V, Clauditz TS, Muenscher A. Prochnow S, et al. Clin Oral Investig. 2019 Aug;23(8):3319-3329. doi: 10.1007/s00784-018-2751-0. Epub 2018 Nov 29. Clin Oral Investig. 2019. PMID: 30498981
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous